Curis
CRIS
#11142
Rank
NZ$4.23 M
Marketcap
NZ$1.75
Share price
-8.26%
Change (1 day)
-39.07%
Change (1 year)

P/S ratio for Curis (CRIS)

P/S ratio as of September 2026 (TTM): 0.3434

According to Curis's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.1908. At the end of 2026 the company had a P/S ratio of 3.14.

P/S ratio history for Curis from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.14133.63%
20251.35-46.65%
20242.52-66.35%
20237.5043.71%
20225.22-87.26%
202140.9-38.66%
202066.81081.79%
20195.65157.53%
20182.19-81.09%
201711.6-79.84%
201657.520.72%
201547.6263.4%
201413.1-18.77%
201316.1-0.2%
201216.2-33.39%
201124.3155.42%
20109.50-62.68%
200925.5347.65%
20085.6950.44%
20073.78-9.14%
20064.16-73.01%
200515.4-69.21%
200450.1203.15%
200316.5829.16%
20021.78-98.93%
2001167

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Pfizer
PFE
2.49 625.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
2.66 673.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
8.22 2,293.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
6.09 1,672.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
> 1000 1,009,840.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.5399 57.24%๐Ÿ‡บ๐Ÿ‡ธ USA